Jiro Kogo is an expert in Ophthalmology at Akita University (Japan). Jiro Kogo has authored 47 publications, the most recent in 2025, and is an investigator in 3 clinical trials. SLR score: 167 (community average: 125). How the SLR is computed.

LeadR Profile

Jiro Kogo Akita University Japan
167 ScienceLeadR Reputation 167
Network Map

Ophthalmology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2004 - 2025

Source: PubMed

Akita University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 47

Citations

Citations: 791 1st author: 10 Last author: 1 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
CLINICAL CHARACTERISTICS AND SURGICAL OUTCOMES OF THE FULL-THICKNESS MACULAR HOLE WITHOUT FOCAL VITREOMACULAR TRACTION: A Multicenter Retrospective Study.
PMID 39642309 — retrospective studies, traction, visual acuity, retinal diseases, retinaldehyde, vitreous body
Retina20240
Novel technique for macular hole-associated retinal detachment with inverted internal limiting membrane flap technique under perfluorocarbon liquid.
PMID 40112317 — retina, air, fluorocarbons, retinal detachment, retinal diseases, retinaldehyde, membranes, vitreous body
Retina20250
ALTERATION OF TREATMENT CHOICES AND THE VISUAL PROGNOSIS FOR DIABETIC MACULAR EDEMA IN THE ERA OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR DRUGS: Analysis of the STREAT-DME 2 Study.
PMID 39423137 — eye, vascular endothelial growth factor a, pharmaceutical preparations, macular edema, therapeutics, retinal diseases, vitreous body, edema, prognosis
Retina20241
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.
PMID 38461843 — safety, therapeutics
Lancet Top journal202479
Subtype prevalence and baseline visual acuity by age in Japanese patients with neovascular age-related macular degeneration.
PMID 36879074 — eye, ophthalmology, visual acuity, macular degeneration, prevalence
Jpn J Ophthalmol20234

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 2
Phase 2/Phase 3 1

By status:

Completed 3

By type:

Interventional 2
Observational 1

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map